Although hit hard by job losses after the acquisition of Upjohn Co., the city of Kalamazoo, Mich., has rebounded to remain a major center for biotech research. In this video interview, The Deal Pipeline's David Holley discusses the steps that the city's venture capitalists and business leaders have taken to ensure the pharmaceutical and biotech sectors continue to thrive there. - George White